The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationJ. Thromb. Thrombolysis 2011, 32(4):399-404
AbstractThe endogenous fibrinolytic system and the ability of the endothelium to release tissue-plasminogen activator (t-PA) play a pivotal role to protect humans from atherothrombotic events. We have recently reported that the decreased capacity for t-PA release in hypertension is restored with chronic blood pressure lowering. Thus, we explored if acute blood pressure lowering has the same effect. The capacity for acute t-PA release was investigated in the perfused-forearm model during stimulation by intra-arterial substance P 8 pmol/min in hypertensive subjects. The procedure was then repeated during acute blood pressure lowering (n = 9) induced by sodium nitroprusside (SNP) infusion or during placebo infusion (n = 3). SNP lowered mean arterial pressure from 108.6 (2.6) to 83.0 (2.6) (mean and SEM) mmHg (P < 0.001). Substance P induced significant increase in t-PA release during both high- and low-pressure conditions (P < 0.01, ANOVA). Peak t-PA release rate was 199 (77) and 167 (41) (mean and SEM) ng/min/l tissue, and accumulated t-PA release was 2,395 (750) and 2,394 (473) ng, during high- and low-pressure conditions, respectively. t-PA release and hemodynamic responses were almost identical during high- and low-pressure conditions (P = ns, for all). Acute blood pressure lowering does not restore stimulated t-PA release from the endothelium in hypertensive subjects. These findings are in contrast to previously described effects of chronic blood pressure treatment. Although data need to be confirmed in a larger study, they suggest that high blood pressure decreases the cellular t-PA pool rather than interferes with release mechanisms of the protein.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to Journal of thrombosis and thrombolysis
- Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy.
- Authors: Ridderstråle W, Ulfhammer E, Jern S, Hrafnkelsdóttir T
- Issue date: 2006 Apr
- Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
- Authors: Labinjoh C, Newby DE, Pellegrini MP, Johnston NR, Boon NA, Webb DJ
- Issue date: 2001 Nov 1
- Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers.
- Authors: Pellegrini MP, Newby DE, Johnston NR, Maxwell S, Webb DJ
- Issue date: 2004 Jul
- Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.
- Authors: Newby DE, Witherow FN, Wright RA, Bloomfield P, Ludlam CA, Boon NA, Fox KA, Webb DJ
- Issue date: 2002 Jan
- Impaired endogenous fibrinolytic capacity in prehypertensive men.
- Authors: Diehl KJ, Weil BR, Greiner JJ, Wright KP, Stauffer BL, DeSouza CA
- Issue date: 2015 Aug